CDSCO Panel approves Eli Lilly proposal to Increase patients number from India 37 to 57 for LY3871801 study Dr. Divya Colin5 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved pharmaceutical...
CDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept Dr. Divya Colin3 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved Dr Reddys...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
Submit PSUR data: CDSCO Panel Tells Shilpa on additional indication of Rheumatoid Arthritis drug Adalimumab Dr. Divya Colin30 Dec 2023 5:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Shilpa for the extrapolation of indications for Adalimumab 100mg/mL approved in...
Roche settles patent lawsuit against Biogen over biosimilar version of rheumatoid arthritis drug Actemra Ruchika Sharma26 Oct 2023 1:30 PM ISTBasel: Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of...
Revise Phase III CT protocol of Olokizumab as a single-arm study: CDSCO Panel Tells Dr Reddys Dr. Divya Colin17 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Dr...
Boehringer unveils 81 percent discounted biosimilar of AbbVie Humira Ruchika Sharma4 Oct 2023 3:30 PM ISTUntil recently, Humira was the world's biggest-selling prescription drug. It had sales of USD 21.2 billion in 2022.
Coherus resolves part of dispute with AbbVie over Humira biosimilar Ruchika Sharma17 Jun 2023 11:00 AM ISTCoherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as the two fight over the terms of launching a...
India rejects patent claim to Pfizer Pooja Bhatia Bhatia8 Sept 2015 10:48 AM ISTIndia has reportedly again denied Pfizer a patent of rheumatoid arthritis drug tofacitinibPfizer has reportedly sought a patent right over rheumatoid...
